Akari Therapeutics Plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tampa, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Akari Therapeutics Plc has filed 726 SEC EDGAR filings since 13 Apr 2012

SEC filing history

Showing 26-50 of 726 matching filings.

Per page
25
Current page
2
F-6/A File 333-185197

F-6/A filing

Filing date
31 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Mar 2026
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-87614

SCHEDULE 13D/A filing

Filing date
04 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-87614

SCHEDULE 13D/A filing

Filing date
04 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-87614

SCHEDULE 13G/A filing

Filing date
04 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36288

DEF 14A

Filing date
02 Feb 2026
Reporting date
02 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-292930

EFFECT filing

Filing date
29 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-292930

UPLOAD filing

Filing date
27 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36288

PRE 14A

Filing date
22 Jan 2026
Reporting date
22 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-289056

424B5

Filing date
17 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .